Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 injection. Furthermore, a recent study showed that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of human cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Aldén, Markus, Olofsson Falla, Francisko, Yang, Daowei, Barghouth, Mohammad, Luan, Cheng, Rasmussen, Magnus, De Marinis, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946961/
https://www.ncbi.nlm.nih.gov/pubmed/35723296
http://dx.doi.org/10.3390/cimb44030073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946961/
https://www.ncbi.nlm.nih.gov/pubmed/35723296
http://dx.doi.org/10.3390/cimb44030073

Ejemplares similares